|
The latest Mainline newsletters for the General Public are listed here. |
For healthcare professionals we have a Mainline newsletter in a Professional version here. |
Mainline |
||
| Volume 2 | November 15, 2005 | Number 11 |
An Exclusive Continuing Education Publication of Acadiana Consultant Pharmacy Service |
||
Medication News & Update
Clinical trial results for Abbott's Tricor and Simdax were presented at the American Heart Association conference
The results from a trial of Abbott's cholesterol treatment Tricor (fenofibrate) failed to meet its primary endpoint of preventing heart attacks and deaths in patients with type 2 diabetes. Separately, the drugmaker reported positive results for injectable drug Simdax (levosimendan) in the treatment of patients with acute decompensated heart failure (ADHF). Data from both trials were presented at the annual meeting of the American Heart Association.
|
[ Home ]
[ About Us ]
[ Assessment Tools ]
[ Sample Consult ] |
